scholarly journals Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging

2018 ◽  
Vol 46 (4) ◽  
pp. 821-830 ◽  
Author(s):  
Gurdip K. Azad ◽  
Benjamin P. Taylor ◽  
Adrian Green ◽  
Ines Sandri ◽  
Angela Swampillai ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Diffusion Weighted Imaging ◽  
Metastatic Breast ◽  
Therapy Response ◽  
Whole Body ◽  
Whole Body Mri ◽  
Diffusion Weighted ◽  
Pet Ct ◽  
18F Fluoride

Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.

2016 ◽  
Vol 85 (2) ◽  
pp. 313-318 ◽  
Author(s):  
Domenico Albano ◽  
Caterina Patti ◽  
Ludovico La Grutta ◽  
Francesco Agnello ◽  
Emanuele Grassedonio ◽  
...  
Keyword(s):  
Diffusion Weighted Imaging ◽  
Whole Body ◽  
Newly Diagnosed ◽  
Whole Body Mri ◽  
Diffusion Weighted ◽  
Pet Ct

scholarly journals Viable tumor tissue detection in murine metastatic breast cancer by whole-body MRI and multispectral analysis

2009 ◽  
Vol 62 (6) ◽  
pp. 1423-1430 ◽  
Author(s):  
Kai H. Barck ◽  
Brandon Willis ◽  
Jed Ross ◽  
Dorothy M. French ◽  
Ellen H. Filvaroff ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Tumor Tissue ◽  
Metastatic Breast ◽  
Whole Body ◽  
Whole Body Mri ◽  
Viable Tumor ◽  
Viable Tumor Tissue ◽  
Multispectral Analysis

Whole body PET(CT) with FDG for treatment monitoring of patients with bone metastatic breast cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 1088-1088
Author(s):  
V. Huyge ◽  
P. Flamen ◽  
P. Bergmann ◽  
L. Ameye ◽  
B. Vanderlinden ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Treatment Monitoring ◽  
Whole Body ◽  
Pet Ct

The Future Role of PET Imaging in Metastatic Breast Cancer

2021 ◽  
Author(s):  
Kim M. Pabst ◽  
Thomas Decker ◽  
David Kersting ◽  
Timo Bartel ◽  
Miriam Sraieb ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Estrogen Receptor Status ◽  
Metastatic Breast ◽  
Ct Imaging ◽  
Whole Body ◽  
Therapeutic Approaches ◽  
Treatment Optimization ◽  
Pet Ct ◽  
Fdg Pet Ct

Background: A variety of therapeutic approaches are employed to treat patients suffering from breast cancer. Likewise, a broad spectrum of imaging ligands has been introduced for non-invasive PET/CT imaging to enable comprehensive tumor characterization and more accurate response evaluation. Summary: In recent years, novel radioactively labelled ligands have been developed for PET/CT imaging in metastatic breast cancer. One promising tracer is [18F]fluoroestradiol, which was recently approved by the Food and Drug Administration. It can be used for a whole-body assessment of estrogen receptor status. Another radionuclide currently under development is [68Ga]Ga-FAPI. In addition to new radionuclides, the field of application for existing tracers like [18F]fluorodeoxyglucose (FDG) were broadened. It has been shown that an early therapeutic response to various therapies can be detected by [18F]FDG PET/CT, which leads to early treatment optimization. Key Message: In this review, we highlighted new tracers and applications of PET/CT imaging as well as therapeutic approaches in patients with advanced breast cancer. Furthermore, we give an outlook on the application of artificial intelligence, immunoPET and liquid biopsy.

scholarly journals Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer

2017 ◽  
Vol 44 (9) ◽  
pp. 1428-1437 ◽  
Author(s):  
Christopher C. Riedl ◽  
Katja Pinker ◽  
Gary A. Ulaner ◽  
Leonard T. Ong ◽  
Pascal Baltzer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Therapy Response ◽  
Contrast Enhanced Ct ◽  
Monitoring Therapy ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Fdg Pet Ct

Whole Body Diffusion-weighted MRI in Metastatic Breast Cancer Patients: The Luton and Dunstable Experience

2016 ◽  
Vol 28 (5) ◽  
pp. e4
Author(s):  
P.V. Joshi ◽  
A.R. Padhani ◽  
M. Kosmin ◽  
E. Chapman ◽  
C.J. Jayasekera ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Metastatic Breast ◽  
Whole Body ◽  
Diffusion Weighted Mri ◽  
Breast Cancer Patients ◽  
Diffusion Weighted

scholarly journals 11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer

Oncotarget ◽  
2017 ◽  
Vol 8 (39) ◽  
pp. 66516-66527 ◽  
Author(s):  
Hinrich Wieder ◽  
Ambros J. Beer ◽  
Konstantin Holzapfel ◽  
Martin Henninger ◽  
Tobias Maurer ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Diffusion Weighted Imaging ◽  
Whole Body ◽  
Recurrent Prostate Cancer ◽  
Whole Body Mri ◽  
Choline Pet ◽  
Diffusion Weighted ◽  
Pet Ct

scholarly journals Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone

Radiology ◽  
2020 ◽  
Vol 297 (3) ◽  
pp. 622-629
Author(s):  
Michael Kosmin ◽  
Anwar R. Padhani ◽  
Andrew Gogbashian ◽  
David Woolf ◽  
Mei-Lin Ah-See ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Bone Scintigraphy ◽  
Metastatic Breast ◽  
Cancer Therapeutics ◽  
Whole Body ◽  
Response Evaluation ◽  
Whole Body Mri
Sign in / Sign up

Export Citation Format

Share Document